In the further validation study, we demonstrated that METTL3 epigenetically stabilized HK2 and SLC2A1 mRNA levels through an m6A-IGF2BP2 and m6A-IGF2BP2/3-dependent mechanism, and therefore support the malignant state of CRC cells. This evidence concerns the gene SLC2A1 and colorectal carcinoma.